Developing therapeutic monoclonal antibodies at pandemic pace
Sign Up to like & getrecommendations! Published in 2020 at "Nature Biotechnology"
DOI: 10.1038/s41587-020-0512-5
Abstract: The time from discovery to proof-of-concept trials could be reduced to 5–6 months from a traditional timeline of 10–12 months. read more here.
Keywords: pandemic pace; monoclonal antibodies; therapeutic monoclonal; antibodies pandemic ... See more keywords